Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance

finance.yahoo.com/news/johnson-johnson-lifts-annual-forecast-124142825.html

In This Article:
Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68.
The pharmaceutical giant reported sales of $23.74 billion, up 5.8% year over year and beating the…

This story appeared on finance.yahoo.com, 2025-07-16 12:41:42.
The Entire Business World on a Single Page. Free to Use →